THRD
Third Harmonic Bio Inc.
NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.00% today
Updated 2026-04-29
Market cap
$242.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$5 – $6
Volume
—
Third Harmonic Bio Inc. (THRD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | — | — | $38000.00 | $35000.00 | $49000.00 |
| Gross profit | — | — | $-38000.00 | $-35000.00 | $-49000.00 |
| Gross margin | — | — | — | — | — |
| R&D | $9.95M | $15.75M | $24.41M | $23.96M | $36.50M |
| SG&A | $1.17M | $3.26M | $13.30M | $19.99M | $22.37M |
| Operating income | $-11.12M | $-19.00M | $-37.71M | $-43.95M | $58.87M |
| Operating margin | — | — | — | — | — |
| EBITDA | $-1.69M | $-29.61M | $-40.26M | $-30.79M | $-45.42M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-12.81M | $-19.00M | $-37.71M | $-30.82M | $-45.47M |
| Interest expense | — | $10.61M | $2.55M | — | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-12.81M | $-29.61M | $-37.71M | $-30.82M | $45.47M |
| Net income growth (YoY) | — | -131.2% | -27.4% | +18.3% | +247.5% |
| Profit margin | — | — | — | — | — |